当前位置: X-MOL 学术Annu. Rev. Cancer Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
WNT and β-Catenin in Cancer: Genes and Therapy
Annual Review of Cancer Biology ( IF 4.7 ) Pub Date : 2020-03-09 , DOI: 10.1146/annurev-cancerbio-030419-033628
Rene Jackstadt 1 , Michael Charles Hodder 1 , Owen James Sansom 1, 2
Affiliation  

The WNT pathway is a pleiotropic signaling pathway that controls developmental processes, tissue homeostasis, and cancer. The WNT pathway is commonly mutated in many cancers, leading to widespread research into the role of WNT signaling in carcinogenesis. Understanding which cancers are reliant upon WNT activation and which components of the WNT signaling pathway are mutated is paramount to advancing therapeutic strategies. In addition, building holistic insights into the role of WNT signaling in not only tumor cells but also the tumor microenvironment is a vital area of research and may be a promising therapeutic strategy in multiple immunologically inert cancers. Novel compounds aimed at modulating the WNT signaling pathway using diverse mechanisms are currently under investigation in preclinical/early clinical studies. Here, we review how the WNT pathway is activated in multiple cancers and discuss current strategies to target aberrant WNT signaling.

中文翻译:


WNT和β-连环蛋白在癌症中的基因和治疗

WNT途径是控制发育过程,组织稳态和癌症的多效性信号传导途径。WNT途径通常在许多癌症中发生突变,从而导致对WNT信号在致癌作用中的广泛研究。了解哪些癌症依赖于WNT活化以及WNT信号传导途径的哪些成分发生突变,对推进治疗策略至关重要。此外,对WNT信号不仅在肿瘤细胞中而且在肿瘤微环境中的作用建立全面的见解是研究的重要领域,并且可能是多种免疫学惰性癌症的有前途的治疗策略。目前正在临床前/早期临床研究中研究旨在使用多种机制调节WNT信号通路的新型化合物。这里,

更新日期:2020-03-09
down
wechat
bug